The approval is based on global Phase III QUANTI studies evaluating Ambelvist's efficacy and safety in adults and children.

A specially coated iron oxide nanoparticle could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging (MRI). In rare cases, the currently used ...

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...

Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...

(Phys.org)—A new type of nanoparticle-based MRI contrast agent demonstrates selectivity for tumor cells over non-cancerous cells, can detect hypoxia, and is sensitive enough allow for the detection of ...

A group of researchers led by Leif Schroeder from the Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie (FMP) have found a way to detect metastases in certain types of cancer in the brain at an ...

Researchers at Massachusetts General Hospital (MGH) have taken a key step forward in developing a new, possibly safer contrast agent for use in magnetic resonance imaging (MRI) exams. Contrast ...

To enhance the visibility of organs as they are scanned with magnetic resonance imaging (MRI), patients are usually injected with a compound known as a contrast agent before going into the scanner.

Reveal's New Manganese-Based MRI Contrast Agent Advances Safer Patient Care · globenewswire.com CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Contrast agents used in MRI scans to improve the ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

Efficient exchange of nutrients between the mother and the fetus critically depends upon the uteroplacental and fetoplacental circulations 1,2,3,4. Placental under-perfusion could contribute to fetal ...

The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.